Xintela AB logo

Xintela AB

Xintela is a Swedish biomedical company working in the fields of regenerative medicine and cancer, with particular focus on cartilage damage and brain tumours.

[stock_market_widget type=”leaderboard” template=”color-frame” color=”yellow” assets=”1XT.BE” api=”yf” style=”font-size: 15px”]

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttp://xintela.se
Founded
Disease Focus
Development Stage
STOCK CODE FRA: 1XT
Address
Medicon VillageSE-223 81
Lund
Sweden
Email
Contact Number
+46 46 275 65 00

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://in.linkedin.com/company/xintela-ab” connections=”true” suffix=””]